Antiplatelet Drugs
Links shared publicly online about this topic
AstraZeneca Confident Oral Antiplatelet Drug Brilinta Will Be Approved By FDA
medicalnewstoday.com — “AstraZeneca says it has responded to the FDA's queries regarding Brilinta, its oral antiplatelet treatment for acute coronary syndromes, and believes its marketing application in the USA will be a” View full resource at medicalnewstoday.com
Most Recently Shared on January 22, 2011 at 9:17 pm By:
AstraZeneca Confident Oral Antiplatelet Drug Brilinta Will Be Approved By FDA AstraZeneca says it has responded to the .. http://dld.bz/Hddz
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures
eurekalert.org — “An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a procedure such as coronary stent placement have an associated increased risk for major adverse cardiovascular events, particularly development of blood clots in stents, according to a study in the Oct. 27 issue of JAMA.” View full resource at eurekalert.org
Most Recently Shared on October 26, 2010 at 9:34 pm By:
Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures: ( JAMA and Arc... http://bit.ly/94oABn
After Careful Consideration Of Risks And Benefits, PPIs And Antiplatelet Drugs Can Be Used Together
medicalnewstoday.com — “Using proton pump inhibitors (PPIs) and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular (CV) disease who are at high risk of upper gast” View full resource at medicalnewstoday.com
Most Recently Shared on November 9, 2010 at 7:05 pm By:
MNT Gastrointestinal Health News
After Careful Consideration Of Risks And Benefits, PPIs And Antiplatelet Drugs Can Be Used Together http://mnt.to/3MhS #gastrointestinal
Proton Pump Inhibitors Do Not Counteract Benefits Of Antiplatelet Drugs Clopidogrel Or Prasugrel In Patients After An Acute Coronary Syndrome
medicalnewstoday.com — “An article published online first and in a future edition of the lancet reports that proton pump inhibitors (ppis) do not interfere with the clinical benefit of the anticlotting drugs clopi” View full resource at medicalnewstoday.com
Most Recently Shared on September 3, 2009 at 10:17 am By:
Proton Pump Inhibitors Do Not Counteract Benefits Of Antiplatelet Drugs Clopidogrel Or Prasugrel In Patients Aft.. http://bit.ly/IPo6g
Antiplatelet drug interactions - Mackenzie - 2010 - Journal of Internal Medicine - Wiley Online Library
onlinelibrary.wiley.com — “Antiplatelet drug interactions - Mackenzie - 2010 - Journal of Internal Medicine - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on December 13, 2010 at 10:17 pm By:
Symposier Cardiology Cardiology and Health Business
Antiplatelet drug interactions. http://bit.ly/i2HaEv
Research suggests antiplatelet drug consumption with low-dose aspirin | Health Jockey
healthjockey.com — “Antiplatelet drugs serve as a potential way to combat blood clotting. According to a research reported in the American Heart Association’s Emerging Science” View full resource at healthjockey.com
Most Recently Shared on June 28, 2011 at 4:44 pm By:
Tammi Jacobs Health Professional
Research suggests antiplatelet drug consumption with low-dose aspirin http://bit.ly/jOrsUP
Antiplatelet drug with on-off switch « Medical Search Tips, News, and Information for Healthcare Professionals
clinicalsearchtips.com — “Antiplatelet drug with on-off switch « Medical Search Tips, News, and Information for Healthcare Professionals” View full resource at clinicalsearchtips.com
Most Recently Shared on September 16, 2009 at 12:25 pm By:
Medical Search Tips: Antiplatelet drug with on-off switch: An investigational treatment for .. http://tinyurl.com/mhs6nf
New study suggests potent antiplatelet drug effective with low-dose aspirin
medicalxpress.com — “When taken with higher doses of aspirin (more than 300 milligrams), the experimental antiplatelet drug ticagrelor was associated with worse outcomes than the standard drug, clopidogrel, but the opposite was true with lower doses of aspirin.” View full resource at medicalxpress.com
Most Recently Shared on June 27, 2011 at 5:00 pm By:
PhysOrg Health News Health News
New study suggests potent antiplatelet drug effective with low-dose aspirin http://tw.medicalxpress.com/228392704
Study examines outcomes of high-dose antiplatelet drug after stent placement
physorg.com — “Modifying a patient's dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient's level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty ...” View full resource at physorg.com
Most Recently Shared on March 15, 2011 at 9:08 pm By:
PhysOrg Health News Health News
Study examines outcomes of high-dose antiplatelet drug after stent placement http://tw.physorg.com/219427381
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement
newswise.com — “Modifying a patient--™s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient--™s level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.” View full resource at newswise.com
Most Recently Shared on March 15, 2011 at 8:23 pm By:
newswise Health Communicator and Health News
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement: Modifying a patient's dosage of th... http://bit.ly/hOcHHY
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement
newswise.com — “Modifying a patient--™s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient--™s level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.” View full resource at newswise.com
Most Recently Shared on March 15, 2011 at 8:21 pm By:
#health news: Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement: Modifying a patient'... http://bit.ly/hmS7Qs
PPIs, antiplatelet drugs can help treat CV disease patients at high risk of upper GI bleeding
news-medical.net — “Using proton pump inhibitors and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular disease who are at high risk of upper gastrointestinal bleeds, despite recent concerns about an adverse interaction between these two types of drugs, according to an Expert Consensus Document released jointly today by the American College of Cardiology Foundation, the American College of Gastroenterology, and the American Heart Association.” View full resource at news-medical.net
Most Recently Shared on November 10, 2010 at 1:10 pm By:
PPIs, antiplatelet drugs can help treat CV disease patients at high risk of upper GI bleeding: Using proton pump... http://bit.ly/bhkSeG
AstraZeneca Confident Oral Antiplatelet Drug Brilinta Will Be Approved By FDA - QualityPoint Technologies
qualitypointtech.net — “AstraZeneca says it has responded to the FDA's queries regarding Brilinta, its oral antiplatelet treatment for acute coronary syndromes, and believes its marketing application in the USA will be approved. The FDA (Food and Drug Administration) had requested further data on Brilinta's intraction with high-dose aspirin...” View full resource at qualitypointtech.net
Most Recently Shared on January 23, 2011 at 10:46 am By:
AstraZeneca Confident Oral Antiplatelet Drug Brilinta Will Be Approved By FDA: AstraZeneca says it has responded t... http://bit.ly/eMewLW
Antiplatelet Drugs- Are Physicians "Nonresponders" When it Comes to Testing?: Neuro Notes
boards.medscape.com — “Imagine if there were tests to determine whether your patient with vascular disease would respond to potentially life saving treatments like aspirin or clopidogrel (Plavix). Well, there are. But does anyone use them?” View full resource at boards.medscape.com
Most Recently Shared on March 17, 2010 at 7:54 pm By:
Andrew Wilner, MD Doctor, Internist, Neurologist, and Physician
Antiplatelet Drugs- Are Physicians "Nonresponders" When it Comes to Testing?: Neuro Notes: http://bit.ly/dz9IaJ via @addthis
New study suggests potent antiplatelet drug effective with low-dose aspirin
newsroom.heart.org — “AHA Newsroom, AHA News, heart news, heart health news, news releases, heart news releases, stroke news releases, stroke news, advocacy news, advocacy news releases, press releases, multimedia, podcast, video, audio interview” View full resource at newsroom.heart.org
Most Recently Shared on June 27, 2011 at 5:44 pm By:
New study suggests potent antiplatelet drug effective with low-dose aspirin: American Heart Association Special ... http://bit.ly/mRyrrB
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
Genetics OW
Organizing genetics resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Gastrointestinal
The latest gastrointestinal news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
